Raymond James & Associates’s Xponential Fitness XPOF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$533K Buy
42,974
+13,962
+48% +$205K ﹤0.01% 3074
2024
Q2
$453K Buy
+29,012
New +$358K ﹤0.01% 3137
2023
Q4
Sell
-46,565
Closed -$722K 3965
2023
Q3
$722K Buy
46,565
+21,836
+88% +$428K ﹤0.01% 2665
2023
Q2
$427K Sell
24,729
-476
-2% -$13.5K ﹤0.01% 3041
2023
Q1
$766K Buy
25,205
+2,950
+13% +$78.1K ﹤0.01% 2635
2022
Q4
$510K Sell
22,255
-67,175
-75% -$1.38M ﹤0.01% 2890
2022
Q3
$1.63M Buy
89,430
+64,110
+253% +$1.08M ﹤0.01% 2100
2022
Q2
$318K Buy
+25,320
New +$456K ﹤0.01% 3193

Other funds holding XPOF

Raymond James & Associates's XPOF Position: Q3 2024 in Review

Raymond James & Associates increased its Xponential Fitness (XPOF) stake by 48% in Q3 2024, buying an estimated $205K and bringing the position to 42,974 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #3074.

Raymond James & Associates first reported a position in XPOF in Q2 2022 and has held it in 8 quarters since. The position peaked at $1.63M in Q3 2022. 113 funds tracked by Wall St. Rank hold XPOF as of Q3 2024.

  • Raymond James & Associates held 42,974 shares of Xponential Fitness worth $533K as of Q3 2024.
  • Raymond James & Associates bought 13,962 Xponential Fitness shares in Q3 2024, an estimated $205K.
  • Xponential Fitness made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3074 holding.
  • Raymond James & Associates first reported a position in Xponential Fitness in Q2 2022 and has held it in 8 quarters since.
  • Raymond James & Associates's Xponential Fitness position peaked at $1.63M in Q3 2022.
  • 113 funds tracked by Wall St. Rank held Xponential Fitness as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.